SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/50526"
 

Search: onr:"swepub:oai:gup.ub.gu.se/50526" > Factors associated ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Factors associated with development of stroke long-term after myocardial infarction: experiences from the LoWASA trial

Herlitz, Johan, 1949 (author)
Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute,[external]
Holm, Johan (author)
Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine
Peterson, M. (author)
show more...
Karlson, Björn W., 1953 (author)
Haglid Evander, Maria, 1946 (author)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
Erhardt, Leif RW (author)
Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups
show less...
 (creator_code:org_t)
Wiley, 2005
2005
English.
In: J Intern Med. - : Wiley. - 0954-6820 .- 1365-2796. ; 257:2, s. 201-7
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVE: To describe factors associated with the development of stroke during long-term follow-up after acute myocardial infarction (AMI) in the LoWASA trial. PATIENTS: Patients who had been hospitalized for AMI were randomized within 42 days to receive either warfarin 1.25 mg plus aspirin 75 mg daily or aspirin 75 mg alone. DESIGN: The study was performed according to the probe design, that is open treatment and blinded end-point evaluation. SETTING: The study was performed in 31 hospitals in Sweden. The mean follow-up time was 5.0 years with a range of 1.7-6.7 years. RESULTS: In all, 3300 patients were randomized in the trial, of which 194 (5.9%) developed stroke (4.2% nonhaemorrhagic, 0.5% haemorrhagic and 1.3% uncertain. The following factors appeared as independent predictors for an increased risk of stroke: age, hazard ratio and 95% confidence interval (1.07; 1.05-1.08), a history of diabetes mellitus (2.4; 1.8-3.4), a history of stroke (2.3; 1.5-3.5), a history of hypertension (2.0; 1.5-2.7) and a history of smoking (1.5;1.1-2.0). Most of these factors were also predictors of a nonhaemorrhagic stroke whereas no predictor of haemorrhagic stroke was found. CONCLUSION: Risk indicators for stroke long-term after AMI were increasing age, a history of either diabetes mellitus, stroke, hypertension or smoking.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

Age Factors
Aged
Anti-Inflammatory Agents
Non-Steroidal/therapeutic use
Anticoagulants/therapeutic use
Aspirin/therapeutic use
Cerebrovascular Accident/*etiology/prevention & control
Female
Follow-Up Studies
Humans
Hypertension/complications
Male
Myocardial Infarction/*complications/drug therapy
Proportional Hazards Models
Regression Analysis
Risk Factors
Smoking/adverse effects
Time Factors
Warfarin/therapeutic use
acute myocardial infarction
stroke

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view